Semaglutide is the active ingredient in Wegovy and Ozempic, a once-weekly injection (or daily Wegovy tablet) that mimics the GLP-1 hormone.
If you have type 2 diabetes
About 11.9% of adults in the city and 12.6% in Los Angeles County have diagnosed diabetes [3] [4]. For them the relevant semaglutide is usually Ozempic, which is approved to control blood sugar in adults with type 2 diabetes and to lower cardiovascular and kidney risks [6]. Medi-Cal's 2026 change targeted adult weight loss; non-weight indications can still be covered if medically necessary [2]. Commercially insured patients whose plan covers it may pay as little as $25 a month with Novo's savings offer, capped at $100 a month in savings [7].
Sponsored placement: open.
One local practice can be featured here. This is a paid, labeled placement and never an endorsement.
Feature your practice in Los Angeles, from $300 a month.
Sponsored means a local business paid for this box. It is labeled, it is not ranked, and our editors do not endorse it.
If you are paying cash for weight loss
| Option | Price per month | Notes | Source |
|---|---|---|---|
| Wegovy pill 1.5 mg | $149 | Starting dose | [1] |
| Wegovy pill 9 mg or 25 mg | $299 | 25 mg is the maintenance dose | [1] |
| Wegovy pen 0.25 to 2.4 mg | $349 | $199 for first two low-dose fills through Dec 31, 2026 | [1] |
| Wegovy HD pen 7.2 mg | $399 | Highest dose | [1] |
At $349 a month, a year of the pen is $4,188, or about 5.1% of the city's $81,939 median household income [5]. The pill is taken each morning on an empty stomach with up to 4 ounces of plain water, then a 30-minute wait before food, drink or other pills [8]. Our pill vs injection page compares the two.
The January 2027 list price cut
On January 1, 2027, Novo Nordisk plans to lower the list price of Wegovy, Ozempic and Rybelsus to $675 a month [9]. List price is what insurers start from, not what most cash buyers pay, so the NovoCare self-pay prices in the table may matter more to you than the list price change.
Compounded products and California checks
Online sellers in California still market compounded semaglutide. None of it is FDA-approved or FDA-reviewed for safety, effectiveness or quality, and FDA says the sodium and acetate salt forms are separate active ingredients it knows no lawful basis to compound [10]. Pharmacies can be looked up with the California State Board of Pharmacy [11], and physicians with the Medical Board of California [12]. Our compounded semaglutide page has more.
Compare nearby: San Diego, Sacramento, Las Vegas, tirzepatide in Los Angeles and LA weight loss.
Warnings to read first
Acute pancreatitis is on the label, so stomach pain that is severe and keeps going needs urgent care [8]. The rodent thyroid C-cell tumor boxed warning rules out anyone whose own or family history includes MTC or MEN 2. Pairing it with insulin or a sulfonylurea makes lows likelier. Face or throat swelling signals a serious allergic reaction. Per the Wegovy label, stop once pregnant and at least 2 months before trying to conceive. Emergencies: 911.
Questions people ask
Is Medi-Cal still paying for semaglutide?
For adult weight loss, no: that ended January 1, 2026. Diabetes and other non-weight uses can still be covered when medically necessary, and members under 21 kept coverage [2].
What do Los Angeles cash buyers pay for Wegovy?
On Oct 17, 2026, NovoCare listed tablets at $149 to $299 a month, the pen at $349 and the 7.2 mg Wegovy HD pen at $399 [1].
What is the diabetes rate in LA?
Does UCLA run a medical weight program?
UCLA Health's Medical Weight Management Program offers supervised low- and very-low-calorie diets, meal replacements and group classes; its page does not mention anti-obesity drugs [13].
What happens to the list price in 2027?
Novo Nordisk plans a $675 monthly list price for Wegovy, Ozempic and Rybelsus starting January 1, 2027 [9].
Can a California pharmacy compound semaglutide sodium?
FDA says semaglutide sodium and acetate differ from the approved ingredient and it knows of no lawful basis to compound them [10].
Sources
13 cited
- Wegovy self-pay offer, NovoCare Pharmacy. Novo Nordisk (NovoCare), Oct 17, 2026.
- California Medicaid ends coverage of GLP-1 drugs for weight loss. KFF Health News, Jan 9, 2026.
- PLACES data, place, 2025 release: Los Angeles, CA. Centers for Disease Control and Prevention, 2025 release (2023 BRFSS).
- PLACES data, county, 2025 release: Los Angeles County, CA. Centers for Disease Control and Prevention, 2025 release (2023 BRFSS).
- QuickFacts: Los Angeles city, California. U.S. Census Bureau, 2025 estimates and 2020-2024 ACS; accessed 2026-10-17.
- Ozempic label. DailyMed, National Library of Medicine, May 2026.
- Ozempic self-pay pricing, NovoCare Pharmacy. Novo Nordisk (NovoCare), Oct 17, 2026.
- Wegovy label (injection and tablets). DailyMed, National Library of Medicine, Jun 2026.
- Novo Nordisk announces reduction in US list price for Wegovy, Ozempic and Rybelsus. Novo Nordisk via PR Newswire, Feb 24, 2026.
- FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, Oct 1, 2026.
- California State Board of Pharmacy. State of California, accessed 2026-10-17.
- Medical Board of California. Medical Board of California, accessed 2026-10-17.
- Medical Weight Management Program: program overview. UCLA Health, accessed 2026-10-17.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.